GOVXW - GeoVax to Participate in Upcoming November Investor and Industry Events | Benzinga
ATLANTA, GA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that members of its senior management team and other scientific representatives will participate in four upcoming investor and industry events during November. Event details are as follows:
Emerging Growth Conference, November 1-2, 2023, Virtual
Date/Time: November 2, 2023 at 3:55 p.m. ET
Title: GeoVax Corporate Update
Speaker: David Dodd, Chairman & CEO, GeoVax Labs, Inc.
For more information and to register to attend the GeoVax Presentation, please visit Emerging Growth Conference.
BIO-Europe, November 6-8, 2023, Munich, Germany
Senior GeoVax management will host one-on-one meetings with registered attendees. For more information, please visit Bio-Europe. If interested in meeting with management at this event, please contact the company through the conference portal, or directly at info@geovax.com.
Vaccines Summit 2023, November 13-15, 2023, Boston, MA
Date/Time: November 14, 2023 at 8:00 a.m. ET